REGEN BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
REGEN BIOPHARMA, INC. (RGBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 1142.86% for the 12-month period ending 2024-09-30, per its 8-K filed 2024-11-29.
Financial Statements › Notes › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2024-11-29
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-12-31 was 932.98%, a 5.76% increase year-over-year.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2022-12-31 was 882.14%, a 6.93% increase year-over-year.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-12-31 was 824.95%, a 11.03% increase year-over-year.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2020-12-31 was 743.00%.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 920.38%, a 5.94% increase from fiscal 2022.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 868.81%, a 5.32% increase from fiscal 2021.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 824.95%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2024-09-30 | 1142.86% 8-K · filed 2024-11-29 | |||
| 2024-03-31 | 932.98% 10-Q · filed 2024-04-24 | |||
| 2023-12-31 | 932.98% 10-Q · filed 2024-01-19 | |||
| 2023-09-30 | 920.38% 10-K · filed 2023-11-20 | |||
| 2023-06-30 | 907.61% 10-Q · filed 2023-07-25 | |||
| 2023-03-31 | 895.05% 10-Q · filed 2023-04-18 | |||
| 2022-12-31 | 882.14% 10-Q · filed 2023-01-19 | |||
| 2022-09-30 | 868.81% 10-K · filed 2022-11-15 | |||
| 2022-06-30 | 855.05% 10-Q · filed 2022-07-22 | |||
| 2022-03-31 | 841.51% 10-Q · filed 2022-04-21 | |||
| 2021-12-31 | 824.95% 10-Q · filed 2022-01-20 | |||
| 2021-09-30 | 824.95% 10-K · filed 2021-12-22 | |||
| 2021-06-30 | 742.00% 10-Q/A · filed 2021-12-22 | |||
| 2021-03-31 | 0.08% 10-Q · filed 2021-08-18 | |||
| 2020-12-31 | 743.00% 10-Q · filed 2021-08-13 |